These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16710252)

  • 1. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease].
    Timofeeva LA; Alekhin MN; Ugriumov MO; Chumakova OS; Larina VN; Sidorenko BA
    Kardiologiia; 2006; 46(3):30-4. PubMed ID: 16710252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
    Dahlöf B; Gosse P; Guéret P; Dubourg O; de Simone G; Schmieder R; Karpov Y; García-Puig J; Matos L; De Leeuw PW; Degaute JP; Magometschnigg D;
    J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
    Asmar R; Garcia-Puig J; Gosse P; Karpov YA; De Leeuws PW; Magometschniggs D; Matos L; Schmieder R
    Vasc Health Risk Manag; 2007; 3(4):371-80. PubMed ID: 17969366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertrophy of left ventricular myocardium as modifiable risk factor: novel possibilities of correction].
    Bulkina OS; Talitskiĭ KA; Karpov IuA
    Kardiologiia; 2006; 46(3):68-72. PubMed ID: 16710260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.
    Gueyffier F; Subtil F; Bejan-Angoulvant T; Zerbib Y; Baguet JP; Boivin JM; Mercier A; Leftheriotis G; Gagnol JP; Fauvel JP; Giraud C; Bricca G; Maucort-Boulch D; Erpeldinger S;
    J Hum Hypertens; 2015 Jan; 29(1):22-7. PubMed ID: 24739801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
    Pella D
    High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):107-13. PubMed ID: 21950782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ; Lameira D; Guillausseau PJ
    Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
    Mourad JJ; Waeber B; Zannad F; Laville M; Duru G; Andréjak M;
    J Hypertens; 2004 Dec; 22(12):2379-86. PubMed ID: 15614033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative efficacy of fixed dose combinations of perindopril with indapamide and captopril with hydrochlorothiazide in patients with high risk hypertension].
    Nedogoda SV; Marchenko IV; Chaliabi TA; Tsoma VV; Brel' UA; Prokhorova EA
    Kardiologiia; 2005; 45(11):24-6. PubMed ID: 16353060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects.
    Mazza A; Townsend DM; Schiavon L; Torin G; Lenti S; Rossetti C; Rigatelli G; Rubello D
    Biomed Pharmacother; 2019 Dec; 120():109539. PubMed ID: 31627089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
    Waeber B
    Expert Opin Pharmacother; 2005 Oct; 6(13):2291-9. PubMed ID: 16218889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
    Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B
    J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor.
    Levy BI; Duriez M; Samuel JL
    Am J Hypertens; 2001 Jan; 14(1):7-13. PubMed ID: 11206683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.